Katerzia is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Azurity Pharmaceuticals, Inc.. The primary component is Amlodipine Benzoate.
Product ID | 52652-5001_2ddc59f1-dc68-420a-889b-245b54144430 |
NDC | 52652-5001 |
Product Type | Human Prescription Drug |
Proprietary Name | Katerzia |
Generic Name | Amlodipine |
Dosage Form | Suspension |
Route of Administration | ORAL |
Marketing Start Date | 2019-08-15 |
Marketing Category | NDA / NDA |
Application Number | NDA211340 |
Labeler Name | Azurity Pharmaceuticals, Inc. |
Substance Name | AMLODIPINE BENZOATE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-08-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA211340 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2019-08-15 |
Ingredient | Strength |
---|---|
AMLODIPINE | 1 mg/mL |
SPL SET ID: | df673a4d-acb8-444c-a472-c87ab8cbd366 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
52652-5001 | Katerzia | Amlodipine |
33342-015 | Amlodipine | Amlodipine |
33342-016 | Amlodipine | Amlodipine |
0615-6582 | Amlodipine Besylate | Amlodipine |
46287-035 | NORLIQVA | amlodipine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
KATERZIA 88492580 not registered Live/Pending |
Argentum Holdings, LLC 2019-06-27 |